Description
Dopamine β-hydroxylase (DBH) catalyzes the conversion of dopamine to norepinephrine and serves as a marker of noradrenergic cells. DBH antibodies and antibodies for other markers of catecholamine biosynthesis are widely used as markers for dopaminergic and noradrenergic neurons in a variety of applications including depression, schizophrenia, Parkinson’s disease, and drug abuse. The expression of DBH is also elevated during stress.
Synonyms: DBH
Immunogen: peptide from the N-terminal region of human dopamine β-hydroxylase (DBH)
Formulation: Peptide affinity-purified antibody
Isotype:
Applications: western blot
Origin: Animal/Sheep
Stability: 365 days
Application|Immunohistochemistry||Application|Western Blot||Product Type|Antibodies|Polyclonal Antibodies||Research Area|Neuroscience
